Takeda Pharmaceuticals Acquites Brazil’s Multilab To Boost Ex-Japan Sales
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals announced the purchase of the mid-sized Brazilian pharmaceutical company Multilab for ¥20 billion on May 25.